Benzinga | Oct 29, 2020 04:48PM EDT

Chemed: Q3 Earnings Insights

Shares of Chemed (NYSE:CHE) were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 40.46% year over year to $4.86, which beat the estimate of $3.97.

Revenue of $528,297,000 rose by 9.92% year over year, which beat the estimate of $514,210,000.

Guidance

Chemed hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Price Action

52-week high: $528.29

52-week low: $330.01

Price action over last quarter: down 4.65%

Company Description

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. It also manufactures products and equipment used to provide these services. Chemed generates the majority of its revenue from business in the United States.